1 Research Designs For Evaluating Disease Management Program Effectiveness Ariel Linden, Dr.P.H., M.S. President, Linden Consulting Group Disease Management.

Slides:



Advertisements
Similar presentations
Solve this equation to find x
Advertisements

1 Yell / The Law and Special Education, Second Edition Copyright © 2006 by Pearson Education, Inc. All rights reserved.
Quantitative Methods Topic 5 Probability Distributions
Ozone Level ppb (parts per billion)
Multiplication X 1 1 x 1 = 1 2 x 1 = 2 3 x 1 = 3 4 x 1 = 4 5 x 1 = 5 6 x 1 = 6 7 x 1 = 7 8 x 1 = 8 9 x 1 = 9 10 x 1 = x 1 = x 1 = 12 X 2 1.
Division ÷ 1 1 ÷ 1 = 1 2 ÷ 1 = 2 3 ÷ 1 = 3 4 ÷ 1 = 4 5 ÷ 1 = 5 6 ÷ 1 = 6 7 ÷ 1 = 7 8 ÷ 1 = 8 9 ÷ 1 = 9 10 ÷ 1 = ÷ 1 = ÷ 1 = 12 ÷ 2 2 ÷ 2 =
Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Sep. 16, 2005 Lilly Yue, Ph.D.* CDRH, FDA, Rockville MD * No official support.
The Application of Propensity Score Analysis to Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Lilly Yue, Ph.D.* CDRH, FDA,
THE USE OF HISTORICAL CONTROLS IN DEVICE STUDIES Vic Hasselblad Duke Clinical Research Institute.
June 25, 2006 Propensity Score Adjustment in Survival Models Carolyn Rutter Group Health Cooperative AcademyHealth, Seattle WA.
1 Physicians Involved in the Care of Patients with Recently Diagnosed Cancer CanCORS Provider Composition Writing Group Academy Health Annual Research.
/4/2010 Box and Whisker Plots Objective: Learn how to read and draw box and whisker plots Starter: Order these numbers.
AYP Changes for 2007 K-20 Videoconference June 11, 2007 Presented by: JoLynn Berge OSPI Federal Policy Coordinator.
Half Life. The half-life of a quantity whose value decreases with time is the interval required for the quantity to decay to half of its initial value.
2007 ITBS/ ITED Results Cedar Rapids Community Schools.
1 1  1 =.
1  1 =.
2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt ShapesPatterns Counting Number.
Year 6 mental test 15 second questions Numbers and number system Numbers and the number system, Measures and Shape.
DiseaseNo disease 60 people with disease 40 people without disease Total population = 100.
Dr Eva Batistatou. Outline of this presentation… What is epidemiology? The Fundamentals of Epidemiology course What is biostatistics? The Biostatistics.
SURVIVAL AND LIFE TABLES
The basics for simulations
Introduction to Cost Behavior and Cost-Volume Relationships
1 Price Risk Management and the Futures Market Hedging.
Look at This PowerPoint for help on you times tables
CHAPTER 16 Life Tables.
1 FaCES Clinic and Evaluation A Collaborative Effort….
Different Methods of Impact Evaluation
Effects on UK of Eustatic sea Level rise GIS is used to evaluate flood risk. Insurance companies use GIS models to assess likely impact and consequently.
STANDARDIZED RATES AND RATIOS
Assessing Validity of Association
Statistics Review – Part I
MS in Iceland MS ID MS ID Meaningful patient involvement Dr. Sverrir Bergmann.
Lecture 3 Validity of screening and diagnostic tests
Comparison of X-ray diffraction patterns of La 2 CuO 4+   from different crystals at room temperature Pia Jensen.
Panel II Efficient Court Administration SURVEY Commercial Enforcement and Insolvency Systems Legal Vice Presidency The World Bank.
Hypothesis Testing and Sample Size Calculation Po Chyou, Ph. D. Director, BBC.
2011 WINNISQUAM COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=1021.
Before Between After.
Benjamin Banneker Charter Academy of Technology Making AYP Benjamin Banneker Charter Academy of Technology Making AYP.
2011 FRANKLIN COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=332.
WALWORTH COUNTY COMMUNITY HEALTH SURVEY – January 2012
Subtraction: Adding UP
Real vs. Nominal GDP Unit Seven, Lesson Two Economics Unit Seven, Lesson Two Economics.
Number bonds to 10,
Beat the Computer Drill Divide 10s Becky Afghani, LBUSD Math Curriculum Office, 2004 Vertical Format.
What can Actavis contribute for the sustainability in the health care system?
Chapter 8 Estimation Understandable Statistics Ninth Edition
Plan B ® Actual Use and Behavior Studies NDA NDAC & ACRHD Joint Meeting December 16, 2003 Jin Chen, MD, PhD Division of OTC Drug Products NDAC &
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Evaluation Procedures
Schutzvermerk nach DIN 34 beachten 05/04/15 Seite 1 Training EPAM and CANopen Basic Solution: Password * * Level 1 Level 2 * Level 3 Password2 IP-Adr.
Experimental Research Designs
Correlation AND EXPERIMENTAL DESIGN
Research Design and Validity Threats
Non-Experimental designs: Developmental designs & Small-N designs
Types of Group Designs ____________ group design. The experiment compares groups that receive or _______________ the IV (control group) e.g., behavior.
Non-Experimental designs: Developmental designs & Small-N designs
Experimental Research
EVALUATING YOUR RESEARCH DESIGN EDRS 5305 EDUCATIONAL RESEARCH & STATISTICS.
Experimental Design The Gold Standard?.
Consumer Preference Test Level 1- “h” potato chip vs Level 2 - “g” potato chip 1. How would you rate chip “h” from 1 - 7? Don’t Delicious like.
Research methods and statistics.  Internal validity is concerned about the causal-effect relationship in a study ◦ Can observed changes be attributed.
Introduction section of article
Evaluating Impacts of MSP Grants Ellen Bobronnikov Hilary Rhodes January 11, 2010 Common Issues and Recommendations.
Research Design ED 592A Fall Research Concepts 1. Quantitative vs. Qualitative & Mixed Methods 2. Sampling 3. Instrumentation 4. Validity and Reliability.
Quasi Experimental and single case experimental designs
BHS Methods in Behavioral Sciences I May 9, 2003 Chapter 6 and 7 (Ray) Control: The Keystone of the Experimental Method.
Chapter 18: Experimental and Quasi-Experimental Research
Presentation transcript:

1 Research Designs For Evaluating Disease Management Program Effectiveness Ariel Linden, Dr.P.H., M.S. President, Linden Consulting Group Disease Management Colloquium June 27-30, 2004

2 Whats the Plan? Discuss threats to validity Provide methods to reduce those threats using currently-used evaluation designs Offer additional designs that may be suitable alternatives or supplements to the current methods used to assess DM program effectiveness

3 Selection Bias Loss to Attrition Maturation Benefit Design Unit Cost Increases Regression to the MeanCase-mix Treatment Interference Access New Technology Hawthorne Effect Reimbursement Seasonality Secular Trends Measurement Error

4 Selection Bias Definition: Participants are not representative of the population from which they were drawn: Motivation Severity or acuteness of symptoms Specifically targeted for enrollment

5 Selection Bias (cont) Fix #1: Randomization How: Distributes the Observable and Unobservable variation equally between both groups Limitations: costly, difficult to implement, intent to treat, not always possible

6 Pretest-posttest Control Group:R O 1 XO 2 R O 3 O 4 Solomon 4-Group Design: R OXO R O O R XO R O Selection Bias (cont)

7 Fix #2: Standardized Rates How: Direct/indirect adjustment enables comparisons over time or across populations by weighting frequency of events Limitations: does not control for unobservable variation

8 Age-adjusted Program Results Age Group Pre-Program (rate/1000) r X P Program (rate/1000) r X P Proportion (P) of Population 20 – – – – Adjusted rate

9 Tenure-adjusted Program Results Baseline GroupCompared to inflation- adjusted… 2003 prevalent groups 2003 claims 2003 prevalent groups 2004 claims plus 2004 incident group assumed to have cost 2003 prevalent groups claims in 2003 Baseline GroupCompared to inflation- adjusted… 2002 prevalent groups 2003 claims 2003 prevalent groups 2004 claims 2003 Newly incident members actual claims, Newly incident members actual claims, 2004

10 Selection Bias (cont) Fix #3: Propensity Scoring What?: Logistic regression score for likelihood of being in intervention How: Controls for Observable variation Limitations: does not control for unobservable variation

11 1 st Year CHF Program Results Intervention (N=94) Control Group (N=4606) P(T<=t) two-tail Age NS % Female NS % Portland p< Pre-Hospitalization p< Pre-ED0.70.4p=0.003 Pre-Costs $18,287 $8,974p< Post-Hospitalization p=0.008 Post-ED NS Post-Costs $11,874 $16,036p=0.005

12 1 st Year CHF Program Results Admits

13 1 st Year CHF Program Results ER Visits

14 1 st Year CHF Program Results Costs

15 1 st Year CHF Program Results Propensity Scoring Method Cases (N=94) Matched Controls (N=94) P(T<=t) two-tail Propensity Score NS Age NS % Female0.51 NS % Portland0.17 NS Pre-Hospitalization NS Pre-ED NS Pre-Costs $18,287 $17,001NS Post-Hospitalization Post-ED Post-Costs $11,874 $24,

16 1 st Year CHF Program Results Propensity Scoring Method - Admits

17 1 st Year CHF Program Results Propensity Scoring Method – ED Visits

18 1 st Year CHF Program Results Propensity Scoring Method – Costs

19 Regression to the Mean Definition: After the first of two related measurements has been made, the second is expected to be closer to the mean than the first.

20 Regression to the Mean CAD Where the 1st Quintile (N=749) Went In Year 2 Where the 5th Quintile (N=748) Went In Year 2

21 Regression to the Mean CHF Where the 1st Quintile (N=523) Went In Year 2 Where the 5th Quintile (N=537) Went In Year 2

22 Regression to the Mean (cont) Fix #1: Increase length of measurement periods How: Controls for movement toward the mean across periods Limitations: periods may not be long enough, availability of historic data

23 Regression to the Mean (cont) Currently-Used Method

24 Regression to the Mean (cont) Valid Method (from Lewis presentation)

25 Regression to the Mean (cont) Fix #2: Time Series Analysis How: Controls for movement across many periods (preferably > 50 observations) Limitations: availability of historic data, change in collection methods

26 Measurement Error Definition: Measurements of the same quantity on the same group of subjects will not always elicit the same results. This may be because of natural variation in the subject (or group), variation in the measurement process, or both (random vs. systematic error).

27 Measurement Error (cont) Fix #1: Use all suitables in the analysis (to adjust for the zeroes) Fix #2: Use identical data methods pre and post (like unit claims-to-claims comparison) Fix #3: Use utilization and quality measures instead of cost.

28 Alternative Designs Survival Analysis Time Series Analysis Time-dependent Regression

29 Survival Analysis Features: Time to event analysis – longitudinal Censoring Allows for varying enrollment points

30 Survival Analysis

31 Survival Analysis

32 Time Series Analysis Features: Longitudinal analysis Serial Dependency (autocorrelation) Does not require explanatory variables Controls for trend and seasonality Can be used for forecasting

33 Time Series Analysis (cont)

34 Time-dependent Regression Combines important elements of other models to create a new method, including variables such as: Program tenure (censuring) Seasonality (important for Medicare) Can be used for forecasting

35 Simulated hospital admissions per thousand members based on program tenure and month-of-year (months 1-12 represent Jan – Dec of program year 1, and months represent Jan – Dec of program year 2).

36 Conclusions Identify potential threats to validity before determining evaluation method Choose outcome variables that mitigate measurement bias (e.g. all identified members vs those with costs) There is no panacea! Use more than one design to validate results.

37 How does this presentation differ from what you just saw? Lewis approach is the only valid pre- post population-based design in use today But valid = accurate. Valid just means adjustment for systematic error These methods reduce chances of non- systematic error to increase accuracy

38 1.Linden A, Adams J, Roberts N. An assessment of the total population approach for evaluating disease management program effectiveness. Disease Management 2003;6(2): Linden A, Adams J, Roberts N. Using propensity scores to construct comparable control groups for disease management program evaluation. Disease Management and Health Outcomes Journal (in print). 3.Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: An introduction to time series analysis. Disease Management 2003;6(4): Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: An introduction to survival analysis. Disease Management 2004;7(2):XX-XX. References (1)

39 5.Linden A, Adams J, Roberts N. Evaluation methods in disease management: determining program effectiveness. Position Paper for the Disease Management Association of America (DMAA). October Linden A, Adams J, Roberts N. Using an empirical method for establishing clinical outcome targets in disease management programs. Disease Management. 2004;7(2): Linden A, Roberts N. Disease management interventions: Whats in the black box? Disease Management. 2004;7(4):XX-XX. 8.Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: An introduction to the bootstrap technique. Disease Management and Health Outcomes Journal (under review). References (2)

40 9.Linden A, Adams J, Roberts N. Generalizability of disease management program results: getting from here to there. Managed Care Interface 2004;(July): Linden A, Roberts N, Keck K. The complete how to guide for selecting a disease management vendor. Disease Management. 2003;6(1): Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness adjusting for enrollment (tenure) and seasonality. Research in Healthcare Financial Management. 2004;9(1): XX-XX. 12.Linden A, Adams J, Roberts N. Strengthening the case for disease management effectiveness: unhiding the hidden bias. J Clin Outcomes Manage (under review). References (3)

41 Software for DM Analyses The analyses in this presentation used XLStat for Excel. This is an Excel add-in, similar to the data analysis package that comes built-in to the program. Therefore, users familiar with Excel will find this program easy to use without much instruction.

42 Questions? Ariel Linden, DrPH, MS